FDG positron emission tomography for evaluating breast cancer
BlueCross BlueShield Association
Record ID 32003000737
English
Authors' objectives:
This Assessment reviews evidence on the use of FDG PET imaging in breast cancer and focuses on 4 specific clinical settings: (1) initial diagnosis of breast cancer; (2) staging axillary lymph nodes; (3) detection of locoregional recurrence or distant metastasis/recurrence; and (4) evaluating response to treatment.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.bcbs.com/blueresources/tec/contact-tec.html
Year Published:
2001
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Tomography, Emission-Computed
- Breast Neoplasms
Contact
Organisation Name:
BlueCross BlueShield Association
Contact Address:
BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name:
tec@bcbsa.com
Contact Email:
tec@bcbsa.com
Copyright:
BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.